The protein kinase 2 inhibitor tetrabromobenzotriazole protects against renal ischemia reperfusion injury

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ka, Sun O ^a   Hwang, Hong Pil ^a   Jang, Jong Hwa ^b   Hyuk Bang, In ^a   Bae, Ui Jin ^a   Yu, Hee Chul ^a   Cho, Baik Hwan ^a   Park, Byung Hyun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Hanseo University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CASEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; DRUG EFFECTS; GENE EXPRESSION; GENETICS; KIDNEY DISEASES; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASEIN KINASE II; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; INFLAMMATION MEDIATORS; KIDNEY DISEASES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84942916700     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14816     Document Type: Article

References (40)

1. Menke, J., Sollinger, D., Schamberger, B., Heemann, U., Lutz, J. The effect of ischemia/reperfusion on the kidney graft. Curr. Opin. Organ Transplant. 19, 395-400 (2014).
2. Chawla, L. S., Amdur, R. L., Amodeo, S., Kimmel, P. L., Palant, C. E. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 79, 1361-1369 (2011).
3. Yu, W. et al. H2O2 activates G protein, ? 12 to disrupt the junctional complex and enhance ischemia reperfusion injury. Proc. Natl. Acad. Sci. USA 109, 6680-6685 (2012).
4. Bae, U. J. et al. SPA0355 attenuates ischemia/reperfusion-induced liver injury in mice. Exp. Mol. Med. 46, e109 (2014).
5. Rodrigo, R., Bosco, C. Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 142, 317-327 (2006).
6. Yu, J. et al. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-? B suppressor. J. Hepatol. 55, 328-336 (2011).
7. Kosieradzki, M., Rowinski, W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant. Proc. 40, 3279-3288 (2008).
8. Hagiwara, S. et al. ETS-GS, a new antioxidant, ameliorates renal ischemia-reperfusion injury in a rodent model. J. Surg. Res. 171, 226-233 (2011).
9. Rong, S. et al. Renal PKC-? deficiency attenuates acute kidney injury and ischemic allograft injury via TNF-?-dependent inhibition of apoptosis and inflammation. Am. J. Physiol. Renal Physiol. 307, F718-F726 (2014).
10. Tsuda, H. et al. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem. Biophys. Res. Commun. 427, 266-272 (2012).
11. Zhang, L., Zhu, Z., Liu, J., Zhu, Z., Hu, Z. Protective effect of N-acetylcysteine (NAC) on renal ischemia/reperfusion injury through Nrf2 signaling pathway. J. Recept Signal Transduct. Res. 34, 396-400 (2014).
12. Graham, K. C., Litchfield, D. W. The regulatory ? subunit of protein kinase CK2 mediates formation of tetrameric CK2 complexes. J. Biol. Chem. 275, 5003-5510 (2000).
13. Bae, J. S. et al. CK2? phosphorylates DBC1 and is involved in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients. Int. J. Cancer 136, 797-809 (2015).
14. Zheng, Y. et al. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma. Clin. Cancer Res. 19, 6484-6494 (2013).
15. Pierre, F. et al. Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. J. Med. Chem. 54, 635-654 (2011).
16. Schwarz, E. M., Van Antwerp, D., Verma, I. M. Constitutive phosphorylation of I? B? by casein kinase II occurs preferentially at serine 293: requirement for degradation of free I? B? . Mol. Cell. Biol. 16, 3554-3559 (1996).
17. Bird, T. A., Schooley, K., Dower, S. K., Hagen, H., Virca, G. D. Activation of nuclear transcription factor NF-? B by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272, 32606-32612 (1997).
18. Kim, K. J. et al. Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-? B activation. Immunology 143, 21-32 (2014).
19. Kweon, S. M. et al. Synergistic activation of NF-? B by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKK?-I? B?, and p38 MAPK. Biochem. Biophys Res. Commun. 351, 368-375 (2006).
20. Shrimali, D. et al. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett. 341, 139-149 (2013).
21. Sajnaga, E., Kubinski, K., Szyszka, R. Catalytic activity of mutants of yeast protein kinase CK2? . Acta Biochim. Pol. 55, 767-776 (2008).
22. Ruzzene, M., Penzo, D., Pinna, L. A. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochem. J. 364, 41-47 (2002).
23. Meggio, F., Shugar, D., Pinna, L. A. Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1. Eur. J. Biochem. 187, 89-94 (1990).
24. Jayasuriya, H., Koonchanok, N. M., Geahlen, R. L., McLaughlin, J. L., Chang, C. J. Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. J. Nat. Prod. 55, 696-698 (1992).
25. Kim, G. S., Jung, J. E., Niizuma, K., Chan, P. H. CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia. J. Neurosci. 29, 14779-14789 (2009).
26. Chiang, W. C. et al. Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury. Free Radic. Biol. Med. 41, 1304-1314 (2006).
27. Zhou, L., Koh, H. W., Bae, U. J., Park, B. H. Aggravation of post-ischemic liver injury by overexpression of insulin-like growth factor binding protein 3. Sci Rep 5, 11231 (2015).
28. Lee, Y. H., Yuk, H. J., Park, K. H., Bae, Y. S. Coumestrol induces senescence through protein kinase CKII inhibition-mediated reactive oxygen species production in human breast cancer and colon cancer cells. Food Chem. 141, 381-388 (2013).
29. Chu, C., He, W., Kuang, Y., Ren, K., Gou, X. Celastrol protects kidney against ischemia-reperfusion-induced injury in rats. J. Surg. Res. 186, 398-407 (2014).
30. Yang, N. et al. Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrol. Dial. Transplant. 23, 91-100 (2008).
31. Sund, S., Reisaeter, A. V., Scott, H., Mollnes, T. E., Hovig, T. Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies. Clin. Nephrol. 62, 121-130 (2004).
32. Yamada, M. et al. Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis. Proc. Natl. Acad. Sci. USA 102, 7736-7741 (2005).
33. Ka, S. O., Song, M. Y., Bae, E. J., Park, B. H. Myeloid Sirt1 regulates macrophage infiltration and insulin sensitivity in mice fed a high-fat diet. J. Endocrinol. 224, 109-118 (2015).
34. Zhang, X. L. et al. Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase. Mol. Cell. Biochem. 358, 287-295 (2011).
35. Jaksch, C., Thams, P. A critical role for CK2 in cytokine-induced activation of NF? B in pancreatic ? cell death. Endocrine 47, 117-128 (2014).
36. Adachi, T., Sugiyama, N., Gondai, T., Yagita, H., Yokoyama, T. Blockade of death ligand TRAIL inhibits renal ischemia reperfusion injury. Acta Histochem. Cytochem. 46, 161-170 (2013).
37. Li, Y. W. et al. Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-? B p65 signal pathway. Gene 542, 46-51 (2014).
38. Schneider, C. C., Hessenauer, A., Gotz, C., Montenarh, M. DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks. Oncol. Rep. 21, 1593-1597 (2009).
39. Bae, U. J. et al. Emodin isolated from Rheum palmatum prevents cytokine-induced ?-cell damage and the development of type 1 diabetes. J. Funct. Food 16, 9-19 (2015).
40. Yoon, H. Y. et al. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem. Pharmacol. 75, 2214-2223 (2008).